Geron Corp. : Geron to Present at the Needham Healthcare Conference

     Geron Corp. : Geron to Present at the Needham Healthcare Conference

MENLO PARK, Calif., April 24, 2013 - Geron Corporation (Nasdaq: GERN) today
announced that John Scarlett, M.D., President and Chief Executive Officer,
will present an overview of the company at 10:00 a.m. Eastern Time on
Wednesday, May 1, at the Needham 12th Annual Healthcare Conference in New York

A live webcast of the presentation will be available at Following the live presentation, the
webcast will be archived and available for replay at the same address for a
period of 30 days.

About Geron

Geron is a biopharmaceutical company developing first-in-class therapies for
cancer, including its telomerase inhibitor, imetelstat, in clinical
development. For more information about Geron, visit


Anna Krassowska, Ph.D.
Investor and Media Relations



This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
information contained therein.

Source: Geron Corp. via Thomson Reuters ONE
Press spacebar to pause and continue. Press esc to stop.